Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

NH2-Cys-Ser-Ser-Val-Thr-Ala-Trp-Thr-Thr-Gly-Cys-Gly-CONH2

EU orphan designation number: EU/3/11/910   
Active ingredient: NH2-Cys-Ser-Ser-Val-Thr-Ala-Trp-Thr-Thr-Gly-Cys-Gly-CONH2
Indication: Treatment of traumatic spinal cord injury
Sponsor: PHARMAXON
Grand Luminy Technopole case 922, Parc Scientifique de Luminy, F-13288 Marseille CEDEX 09, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/10/2011 Orphan Designation EMA/OD/025/11 (2011)7043 of 27/09/2011